Expanding prenatal screening for single-gene disorders
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at a new blood test to screen for single-gene disorders (conditions caused by changes in one gene) during pregnancy. It may help if you or your baby's father carry a genetic disorder, or if an ultrasound shows signs of a possible genetic condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and pregnant at 9 weeks or more.
- You or your baby's father carry a single-gene disorder, or an ultrasound suggests your baby might have one.
- Both you and your partner have the same genetic disorder, or you have one and your partner's status is unknown, or a special genetic test showed increased risk.
- You allow the study to collect your baby's health info and a cheek swab within 6 months of birth.
- You agree to sign a consent form and follow study steps.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a non-invasive prenatal blood test (NIPD) that can check for certain serious genetic disorders in your baby, instead of using more invasive methods like amniocentesis. If you are at risk of passing on a severe genetic condition, this test may help you get answers safely.
This study tests a new blood test that can screen for genetic problems in babies during pregnancy. It may find more conditions than standard tests, especially for pregnancies with certain ultrasound findings or other risk factors.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
This study follows pregnant people who had unusual noninvasive prenatal blood test results, to better understand the natural course and possible causes, including concerns about maternal cancer. You may join during pregnancy or up to 2 years after delivery, and you would share medical information and undergo follow-up visits.
This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.
Hear when a new Single Gene NIPT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.